#Convalescentplasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Vanessa Piechotta et al included 20 studies with 5443 participants, of whom 5211 received convalescent plasma. 
https://t.co/vMdc5fy1Z4
#ISBTScience https://t.co/9EMIBGZsE1
#Convalescentplasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Vanessa et al Piechotta included 20 trials with 5443 participants, or Whom 5211 received convalescent plasma.
https://t.co/vMdc5fy1Z4
#ISBTScience https://t.co/9EMIBGZsE1
A society of professionals where knowledge is built and expertise is shared about #transfusionmedicine and related therapies globally #ISBT2020
A society of professionals where knowledge is built and expertise is shared about #transfusionmedicine and related therapies globally # ISBT2020